In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: ACAD’s PERT-weighted fair value at $23.91 suggests an 11.8% upside from the $21.39 price, supported by high confidence and zero downside risk in Monte Carlo analysis. Divergent valuation methods, notably a negative DCF versus high P/E and analyst targets, indicate valuation uncertainty. Financial health is excellent, enhancing stability amid moderate growth prospects.